'Biomarkers as an emerging growth area' is a project with partners representing ICT, Pharma and users. The project held a conference on 2. March 2017 on patient involvement in medical research
At the seminar the overall subject was how to involve patients in medicines development: what are the benefits and what are the drawbacks - how may the pressent approach be approved?
The seminar for the first time brought together public partners, patient organisations and the medical industry to discuss this issue, which is increasingly on the agenda at a European and a national level.
Central questions as the below came up during the day and initiated fruitful discussions among the audience and the presenters.
BRANDBASE, Biopeople and InfinIT are partners in the project which is funded by the Research and Innovation agency.
KORA, the Danish Institute for Local and Regional Government Research hosted the seminar.